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The potential of matrix-assisted laser desorption ionization (MALDI) and MALDI-post-source
decay (PSD) time-of-flight mass spectrometry for the characterization of peptides and proteins
is discussed. Recent instrumental developments provide for levels of sensitivity and accuracy
that make these techniques major analytical tools for proteome analysis. New software
developments employing protein database searches have greatly enhanced the fields of
application of MALDI-PSD. Peptides and proteins can be easily identified even if only a partial
sequence information is determined. Derivatization procedures have been optimized for
MALDI-PSD to increase the structural information and to obtain a complete peptide sequence
even in critical cases. They are fast, simple and can be performed on target. MALDI-PSD is also
a very powerful tool to characterize or elucidate post-translational or chemically induced
modifications. In association with database searches, proteins issued from electrophoretic gels
can be identified after specific enzymatic cleavages and peptide mapping. (J Am Soc Mass
Spectrom 1999, 10, 91–103) © 1999 American Society for Mass Spectrometry
Recent improvements of matrix-assisted laser de-sorption ionization (MALDI) time-of-flight(TOF) mass spectrometry in resolving power,
sensitivity and versatility made this analytical method
highly competitive for the detection and characteriza-
tion of biocompounds such as peptides and proteins
[1–3]. The tolerance of the MALDI process towards
contaminants typically employed in biochemistry such
as buffer salts and detergents, in association with the
ability of time-of-flight mass spectrometry to analyze
unseparated mixtures of analytes, limits the number of
necessary preparation steps and, therefore, reduces the
loss or consumption of analyte material. The simplicity
and rapidity of the MALDI sample preparation, fast
data acquisition and the coupling of the mass spectrom-
eter to intelligent interpretation software and protein
databases, make this analytical method ideally suited
for routine identification of peptides and proteins.
In this Account and Perspective, MALDI post-source
decay will be described and its analytical possibilities in
the field of peptide sequencing employing database
searches and on-target derivatization methods will be
presented. Identification and localization of post-trans-
lational or chemical modifications will also be demon-
strated. Finally, a simple strategy for rapid and unam-
biguous protein identification will be presented.
MALDI Time-of-Flight Mass
Spectrometry
MALDI was introduced in 1988 by Karas and Hillen-
kamp [4]. It is based on the use of organic matrices
strongly absorbing the wavelength of the laser used
(often a pulsed nitrogen laser at 337 nm) to desorb and
ionize in a relatively soft manner intact high mass
compounds. MALDI as a discontinuous ion production
method is naturally coupled to discontinuous mass
analyzers. TOF mass spectrometers are possibly the
simplest mass analyzers by principle, and are ideally
suited for MALDI ion sources. The ability of the MALDI
technique in analyzing different classes of biomolecules
(peptides, proteins, polysaccharides, polynucleo-
tides, . . . ) has been thoroughly demonstrated [5–9]. In
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1995, Brown and Lennon [10] introduced time-lag fo-
cusing [or delayed extraction (DE)], allowing MALDI-
TOF mass spectrometry to gain competitiveness in both
resolution and mass accuracy with respect to other
mass analyzers. Mass resolutions exceeding 4000
(FWHM definition) have been observed in linear TOF
under DE conditions [11, 12] with mass accuracies the
range of a few ppm [13]. In reflectron MALDI-TOF
mass spectrometry performed under DE conditions, a
mass resolving power of better than 10,000 (FWHM
definition) has been observed, and mass accuracies are
in the range of a few ppm [14–16].
MALDI Post-Source Decay
With reflectron time-of-flight mass spectrometers, it is
in theory possible to obtain structural information on a
selected quasimolecular ion by mass analysis of daugh-
ter ions issued from in-flight fragmentation of the
parent ion. Intact molecular ions leaving the ion source
and having acquired sufficient internal energy during
the desorption process (photoactivation, low energy
collisions, . . . ) can release this energy by undergoing
fragmentation while traveling the first field-free drift
path of the instrument (called post-source decay, or
PSD [17–21]). The fragment ions have the same velocity
as their precursor ions but have different energy as a
function of their mass. Fragment ions are then discrim-
inated as a function of their kinetic energy (thus their
mass) by the time dispersions induced by the electro-
static reflector. Larger fragment ions (with higher ki-
netic energy) will penetrate deeper into the reflectron
than smaller fragment ions and will appear at a later
time on the resulting reflectron time-of-flight spectrum.
The principle of MALDI post-source decay TOF mass
spectrometry is illustrated in Figure 1. With typical
reflectors (single stage, two stage, gridded/gridless
[22]), it is necessary to progressively decrease the po-
tential(s) applied to the reflector to acquire a complete
product-ion spectrum by concatenation of several sec-
tions. Different from that, a so-called curved-field re-
flector is able to disperse all PSD ions over the acquired
time-of-flight spectrum with the same set of electro-
static potentials applied to the reflector. A complete
PSD ion spectrum can thus be acquired within a single
step [23]. The performance of this approach, however,
has not been shown so far to be superior to stepped-
mode PSD instruments.
Mass calibration of PSD spectra is more complicated
and usually less precise than stable-ion calibration. PSD
ion masses can be calibrated by a polynomial fit proce-
dure or, in the case of single-stage or two-stage gridded
Figure 1. Principle of MALDI-PSD time-of-flight mass spectrometry (see text).
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reflectors, by calculation of the total flight times
through the instrument. MALDI-PSD under delayed
extraction conditions, first studied mechanistically by
Kaufmann et al. [24], allows us to detect PSD ions of
peptides up to mass 3000 u with unit mass resolution
over the entire production mass range. Under these
conditions, mass accuracy of PSD ions is generally
better than 0.2 u, which is sufficient for structure
elucidation in most applications.
In certain cases, the overall fragmentation yield of a
precursor ion is too low for an unequivocal structural
interpretation. This can be the case when working
under DE conditions. In DE the initial field-free expan-
sion of the ion plume over, e.g., 500 ns reduces the
number of energetic collisions between molecular ions
and neutral matrix molecules during subsequent accel-
eration and therefore reduces the total internal energy
acquired by the molecular ions [24]. For these cases,
high-energy collisions can be employed by means of a
collision cell that is located in the first field-free drift
path. High energy collisions generally increase the yield
of PSD ions at the lower mass end of the fragment ion
spectrum by approximately an order of magnitude, but
tend not to affect or even decrease the yield of the
higher mass end of the spectrum. If the pressure of the
collision cell is too high, high mass PSD ions can be
totally suppressed.
Optimization of MALDI post-source decay time-of-
flight mass spectrometry has been a major topic of our
research group in Duesseldorf. One of the key points for
acquisition of PSD spectra with maximized sensitivity
and accuracy is the overall geometry of the instrument.
We recently developed a fully co-axial time-of-flight
mass spectrometer dedicated to MALDI-PSD. Among
the instrumental features are a fully co-axial ion source,
a high performance ion gate [25, 26] providing for
low-resolution (M/DM ' 200) MS/MS analysis, a lin-
ear detector allowing high mass analysis, and a large
area reflex mode detector. With this TOF mass spec-
trometer, full PSD spectra from peptides with total
sample amounts as low as 30 fmol have been success-
fully recorded and their amino acid sequences have
been determined. The main characteristic of this instru-
ment is its excellent overall ion transmission. Figure 2
displays a positive-ion PSD spectrum obtained from 500
fmol of substance P deposited on target, using 2,5-
dihydroxy benzoic acid as matrix, recorded under de-
layed extraction conditions without employing the col-
Figure 2. MALDI-PSD time-of-flight mass spectrum of positive ions issued from 500 fmoles of
substance P deposited on target using a-cyano-4-hydroxy cinnamic acid as matrix and acquired at 20
kV under delayed extraction conditions. Fragment ion signals can be observed throughout the whole
mass range with equal intensities and with unit mass resolution.
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lision cell. The signal-to-noise improvements due to the
delayed extraction conditions in addition to the high
ion transmission of the instrument largely compensate
for the decrease of molecular-ion decay under delayed
extraction [24].
Peptide Identification by MALDI
Post-Source Decay
Peptide sequencing has become a major field of appli-
cation of the MALDI-PSD technique, driven by the
growing analytical demand. Sequencing peptides by
mass spectrometry has several advantages compared to
classical sequencing methods like Edman degradation
in certain fields of application. The first and most
important is the ability to perform sequence analysis
from a peptide within a mixture because it can be mass
selected by the instrument (for TOF analyzers via an ion
gate, Figure 1). The second advantage is that the frag-
mentation of a molecular ion is not in any case blocked,
for example, by the presence of an N-terminal modifi-
cation, a considerable problem of the Edman degrada-
tion procedure. The third advantage is the subpicomole
sample amount necessary for analysis. Practically, a
combination of both approaches can give in many cases
a complete sequence answer. One of the drawbacks of
peptide sequencing by MALDI-PSD, on the other hand,
is the relatively complex interpretation of fragment ion
spectra. Generally a PSD spectrum recorded from a
singly charged peptidic molecule contains mass signals
coming from immonium ions [27], N-terminal fragment
ions (a-, b-, c-, and d-type ions) [28–30], C-terminal
fragment ions (x-, y-, and z-type ions) [31] and internal
(double chain cleavage) fragment ions (AY-, BY-, and
CY-type ions). Furthermore, all these ions potentially
display satellite peaks at minus 17 mass units due to
loss of ammonia (NH3) from lysine or arginine, or at
minus 18 mass units due to loss of H2O from serine or
threonine. Peptide fragment ion nomenclature can be
found in [32, 33]. As a consequence of the complexity of
spectra, unambiguous sequencing of unknown peptides
is not always possible. To decode a PSD ion spectrum
one needs to follow a set of established interpretation
rules, some of them having been elaborated from em-
pirical findings. Following the interpretation protocol
listed in Table 1 one can usually find partial sequence
information, which can be used to search databases to
obtain the full sequence.
In many cases, it is possible to retrieve the full
amino-acid sequence from a PSD spectrum [26]. We
have developed in Duesseldorf a PC-based algorithm,
“PepSeq,” capable of decoding PSD ion spectra of
peptides based on pre-established interpretation rules
[34]. Using the peak masses determined from the PSD
ion spectrum, PepSeq delivers a set of sequence prop-
ositions by combinatory calculations. For each sequence
proposition, a ranking coefficient is calculated, based on
the level of correspondence between the theoretical
(rule-based) fragmentation pattern of the sequence
proposition (N-terminal, C-terminal, and internal frag-
ment ions) and the PSD spectrum. Each proposed
sequence can then be searched in a protein database.
The following example demonstrates the ability of
PepSeq in decoding PSD spectra. Figure 3a displays the
PSD ion spectrum of a bioactive peptide of molecular
weight 1135.7 u. Looking at the small mass fragment
ions of this spectrum, one can detect the presence of
four different amino acids in the peptide sequence: R
(70, 87, and 112 u), I/L (86 u), F (120 u) and Y (136 u).
Owing to missing ion signals, the amino acids H, K, P,
Q, T, V, and W can be ruled out as being constituents of
the sequence. Furthermore, because there is a charac-
teristic PSD ion signal at 175 u, an arginine residue (R)
can be assumed to be located at the C terminus of the
sequence (first y fragment ion). In addition to the mass
of the peptide and the peak masses of the PSD spec-
trum, all of the above informations are used by PepSeq.
Calculation time is dependent on the length of the
peptide and on the number of detected PSD ion signals.
For the first ten resulting sequence propositions (Table
2), the ranking coefficients are quite high and within the
same range. The first seven proposed sequences have
all in common the last four amino acids -RRLR-OH.
This is a strong indication that the last part of the
sequence is correctly identified. Each sequence propo-
sition can then be searched in a protein database. Only
the third proposed sequence was found in the nonre-
dundant protein database and was identified as dynor-
phin 1-9 (Table 2). Figure 3b displays the PSD spectrum
superimposed with the labels of the observed fragment
ions of dynorphin 1-9 (N- and C-terminal fragment ions
only). The nonlabeled fragment ion signals can in most
Table 1. PSD fragment ion spectrum interpretation protocol
Operation Resulting information
Information on origin of the peptide (e.g., digestion enzyme) Identification of the AA from N or C terminus
Small mass ion screening (immonium ions) Identification of some AA of the sequence
Other AA can be ruled out
Search for b/y correspondences Establishment of a partial (or total) sequence information
Search for characteristic ion patters (i.e., b, b-[NH3], a, a-
[NH3], giving signals at m, m-17, m-28, m-45)
Identification of b and y ions f Orientation of the
sequence established above
Search for characteristic internal fragment ions (e.g.,
fragment ions due to the presence of proline of the form:
[P 1 nAA]1 with n $ 1)
Partial sequence identification or confirmation of a pre-
established sequence
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Figure 3. (a) MALDI-PSD time-of-flight mass spectrum of positive ions issued from a peptide at
mass 1135.7 u using 2,5-dihydroxy benzoic acid as matrix and acquired at 10 kV under delayed
extraction conditions. (b) Same spectrum on which the fragmentation scheme of Dynorphin
(YGGFLRRIR) has been superimposed.
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cases be attributed to internal fragment ions and can be
interpreted by the algorithm. The good match between
the spectrum and the fragmentation scheme indicates
that the proposed sequence is correct.
With the PepSeq algorithm, the probability of find-
ing the correct sequence of a given peptide within the
first ten propositions strongly depends on the quality of
the PSD spectrum. To some extent, it additionally
depends on the fragmentation behavior of the peptide
(sequence dependent) and on the quantity of material
available for analysis. In almost all cases, it is at least
possible to obtain partial sequence information (se-
quence tag), constant within the first (ten) sequence
propositions, which can be used to search databases [35,
36]. Using the previous example (peptide of mass 1137.7
u), we searched sequence tag (538.3)RRLR(1119.7) in
various databases. Twelve different existing sequences
were retrieved by the search, but only two of them
contained all of the previously identified amino acids
constituents of the peptide (FI/LRY): FLYNRRLR and
YGGFLRRIR (dynorphin 1-9). The predicted fragmen-
tation schemes of both sequences were superimposed
on the PSD spectrum, and the second sequence propo-
sition (dynorphin 1-9) has a considerably better corre-
spondence. Correct sequence tags generated by
MALDI-PSD TOF mass spectrometry in association
with database searching is a powerful and rapid pep-
tide or protein identification method [37–40].
“De novo” Peptide Sequencing
In certain cases, the partial amino acid sequence even-
tually retrieved from a PSD spectrum is too short or not
specific enough to allow for an unambiguous sequence
identification because the number of proposed se-
quences resulting from a database search is too large.
Furthermore, when dealing with the characterization of
synthetic peptides or when analyzing unknown or
modified proteomic material, it is necessary to identify
fully the sequence. Our strategy to simplify sequence
elucidation using MALDI-PSD is based on the idea of
marking up certain fragment ions (or fragment ion
groups) by specific mass shifts induced by simple
on-target substitutions or derivatizations of the pep-
tides [41]. Because the available sample amounts are
usually very small (subpicomole), a number of prereq-
uisites are essential for performing on-target derivatisa-
tion reactions:
(1) Reactions should work with an already prepared
MALDI sample (sample 1 matrix) at atmospheric pres-
sure and close to room temperature.
(2) Reactions should work in acidic media such as
matrix solutions and should work without the use of
buffers, which would alter the sample recrystallisation
process or would affect the ionization process.
(3) Reactants should be nonionic to avoid alkali-
metal adduct formation.
(4) Reactions should be simple in handling, fast (a
few minutes), singly stepped, should have a high yield
(close to 100%) and should not form nonvolatile side
products that can disturb the sample recrystallisation
and the final sample homogeneity.
(5) Substituents should not decay in the mass spec-
trometer by creating additional PSD ion signals.
The above requirements limit the number of possible
reaction types and reactants. In the following, we de-
scribe two basic on-target substitution and derivatiza-
tion methods that can be used consecutively on the
same sample.
The first derivatization method, intensively used in
our laboratory, is hydrogen–deuterium exchange
(H/D) [42]. After exchange of all exchangeable hydro-
gen’s with deuterium (i.e., all hydrogen atoms bound to
noncarbon atoms), the gain of information on a peptide
sequence is twofold: first, the determination of the exact
number (n) of exchangeable hydrogens of the peptide
(n 5 [M 1 D]1 2 [M 1 H]1) will automatically de-
crease the number of propositions obtained through a
database search to about 10%. Second, the specific mass
shifts of the PSD fragment ions (depending on the
amino acid constituents of the fragment ion) observed
between the PSD spectrum of the native and that of the
H/D exchanged peptide allow one to confirm or reject
a previously proposed partial or total sequence. The
H/D exchange can be performed with subpicomolar
sample amounts, using deuterated solvents compatible
with the matrix employed. Under a nitrogen stream and
at room temperature, the peptide-plus-matrix crystals
are completely redissolved, and after that are allowed
to recrystallise. This protocol is repeated several times
to obtain an exchange yield of nearly 100% without any
major loss of signal intensity. The exchange can be
reversed by using H-containing solvents.
The second on-target derivatization method used
routinely in our laboratory is based on the idea of
Table 2. First ten amino acids sequences proposed by PepSeq
after analysis of the PSD spectrum in Figure 5a
Database search parameters
Peptide mass: 1135.7 6 0.5 u
PSD ion mass accuracy: 0.75 u
Expected amino acids: FI/LRY
Excluded amino acids: HKPQTVW
Expected residue at C terminus: R
Database search results—sequence propositions
Nb Sequence Ranking
(Nb of database
hits—peptide name)
1 YNFLRRLR 54.52 0
2 FLNYRRLR 53.76 0
3 YGGFLRRLR 53.34 15-Dynorphin-YGGFLRRIR
4 FLYGGRRLR 53.12 0
5 YFNLRRLR 51.99 0
6 LFNYRRLR 51.62 0
7 GYGFLRLRR 51.53 0
8 YNFLRLRR 51.29 0
9 YGGFLRLRR 51.01 0
10 LFGGYRRLR 50.93 0
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Figure 4. MALDI-PSD time-of-flight mass spectra of positive ions issued from a peptide at mass
1135.7 u using 2,5-dihydroxy benzoic acid as matrix and acquired at 10 kV under delayed extraction
conditions (a) after H/D exchange, (b) in its native state (protonated), and (c) after acylation with
propionic acid. The comparison of all three spectra provided for a complete and unambiguous
sequence determination (see Figure 5).
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Figure 5. Fragmentation scheme obtained after comparison of the three MALDI-PSD fragment ion
spectra of Figure 4.
Figure 6. MALDI-PSD time-of-flight mass spectrum of positive ions issued from a phosphorylated
peptide at mass 1126.5 u using 2,5-dihydroxy benzoic acid as matrix and acquired at 10 kV under
delayed extraction conditions.
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specifically marking N-terminal fragment ions [43].
Acylation reactions are very specific and take place only
on free primary amines (N-terminal and side chain of
lysine) [44]. The gain of information on a peptide
sequence is again twofold: first, the observed mass shift
of the molecular weight will signal the presence of
lysine residues in an amino acid sequence. Second, in
comparison with the PSD spectrum of the native pep-
tide, N-terminal ions formed by PSD are easily discrim-
inated from C-terminal fragment ions due to their mass
shifts of 1[Macyl 1 nMacyl], where Macyl is the mass of
the substituent and (n) the number of lysine residues in
the N-terminal partial sequence. The observed mass
shifts on the N-terminal fragment ions usually allow
one to position the lysine residue(s) in the amino acid
sequence. On-target acylation reactions can be per-
formed with subpicomolar sample amounts in ambient
atmosphere, using volatile anhydrides (such as acetic or
propionic anhydrides) in matrix specific solvents.
A third derivatization method greatly simplifying
PSD spectra interpretation is based on the idea of
exclusively forming a complete series of N-terminal (or
C-terminal) fragment ions by fixing at the N terminus
(C terminus) of the peptide a charge carrying group
[45]. This strategy has been studied successfully re-
cently for picomole or less sample amounts [46].
The following example demonstrates the feasibility
and analytical power of on-target derivatization reac-
tions. The sample was prepared with a-cyano-4-hy-
droxy cinnamic acid as matrix. H/D exchange was
performed using a solvent mixture of acetone d6/
D2O 2 7/3. The MALDI sample was redissolved four
times with 5 mL of the above solvent mixture to com-
plete the exchange reaction. Acylation of the native
(protonated) MALDI sample was performed by using
propionic anydride at 5% in a solvent mixture of
acetone/H2O 2 7/3. The MALDI sample was redis-
solved four times with 5 mL of the above solvent
mixture to complete the derivatization reaction. Mass
analysis of all three molecular ions was performed by
MALDI-TOF mass spectrometry. After H/D exchange
and from the mass uptake of the molecular ion (from
1084.6 to 1103.6 u), the number of exchangeable hydro-
gens was found to be 19. After acylation, the mass
increase for the molecular ion (from 1084.6 to 1196.6 u)
indicated the addition of two propionyl groups (Prop)
on the peptide. The first addition was presumably
located on the N terminus of the sequence. The second
addition is due to the presence of a lysine (K) within the
amino acid sequence.
PSD spectra were acquired for the sample in its
native state [M 1 H]1, after H/D exchange [M 1 D]1
Figure 7. MALDI time-of-flight spectrum of positive ions displaying the peptides issued from a
specific enzymatic cleavage of a protein by the endoprotease glu-c. The spectrum was acquired at 20
kV under delayed extraction conditions.
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and after acylation [M(Prop)2 1 H]
1. All three spectra
are presented in Figure 4. Small mass fragment ion
analysis was performed with all three spectra. Valine
(V), methionine (M), histidine (H), and lysine (K) were
identified as being constituents of the peptide. Using
the PepSeq interpretation software on the PSD ion
spectrum of the unmodified peptide, we found the
sequence HDMNKVLDL proposed with the highest
ranking score. PepSeq is also able to integrate data
produced after on-target derivatization reactions or
after terminal derivatisations. The program then per-
forms an automatic sequence cross-check between
[M 1 D]1 and [M 1 H]1 PSD spectra. In the case of
N-terminal modification (e.g., acylation), it searches for
respective mass shifts of PSD ions and uses this infor-
mation for sequence determination. In the example in
Figure 4, the acylation of the N terminus of the peptide
induced a mass shift of 156 u to all of the N-terminal
fragment ions up to the b4 fragment ion (shift from
498.2 to 554.2 u). The lysine residue (K) must be the fifth
amino acid because starting with the b5 fragment ion
(shifted from 626.3 to 738.3 u), all the N-terminal
fragment ions were shifted by 1112 u (2 3 Prop).
Identification of the N-terminal fragment ions strongly
supported the previously proposed sequence. Compar-
ison between the [M 1 H]1 and the [M 1 D]1 PSD
spectra allowed us to verify the sequence based on the
numbers of exchangeable hydrogen’s of each fragment
ion. Figure 5 shows the fragmentation scheme of the
peptide displaying all of the detected N- and C-terminal
fragment ions in the three PSD fragment ion spectra.
For this sample, the use of MALDI-PSD, in conjunction
with on-target derivatization and with the help of our
peptide sequencing software, provided for a complete
and unambiguous sequence determination.
Localization of Post-translational
Modifications
One of the strong points of MALDI-PSD is its ability to
identify precisely and to locate post-translational or
chemical modifications of amino acid residues within a
peptide sequence [47–49]. This feature is demonstrated
in the following example. Figure 6 displays a PSD
spectrum of a peptide suspected to contain a phosphor-
ylated serine or threonine residue. The presence of a
sequence modification is usually signaled by some
specific fragment ion signals. In the case of phosphor-
ylation, strong fragment ion signals at [M 1 H 2 80]1
due to loss of HPO3 and [M 1 H 2 98]
1 due to losses
of HPO3 and H2O are observed in the spectrum (Figure
6) [50, 51]. Furthermore, immonium ion signals issued
from phosphorylated serine or threonine residue can be
detected. With phosphorylations, the loss of 80 u (98 u)
can also be observed on N-terminal and C-terminal ions
when the modified residue is a constituent of the
fragment ion. Having identified these ion signals, we
find it is straightforward to determine the sequence and
to locate the modified amino acid residue. In the
example the amino acids P (70 u), V (72 u), H (110 u),
Table 3. Observed ion signals and corresponding peptide sequences after specific proteolysis of phosphoenolpyruvate protein
phosphotransferase by the endoprotease glu-c (monoisotopic values of protonated molecular ions)
Obs. mass (u)
[M 1 H]1 (monois.) Sequence
Calc. mass (u)
[M 1 H]1 (monois.)
Mass diff.
(ppm)
570.25 YMKE 570.26 7
617.32 NLKNE 617.33 11
849.47 LVNNYVK 849.48 11
874.47 KENLKNE 874.46 211
886.51 AKAILLEE 886.53 12
978.48 VAKFNSAIE 978.53 50
1000.44 GHDISDDIE 1000.42 222
1056.55 RYFADKKE 1056.55 24
1058.59 LTKIRNNAE 1058.60 5
1135.62 LIAYQDKRE 1135.61 211
1143.61 AKAILLEEKE 1143.66 42
1278.65 NGAQGIGLYRTE 1278.64 25
1356.77 IPAIVGTKSITQE 1356.77 1
1416.77 IPATAALADVFAKE 1416.77 4
1438.82 LIQPIDKIKNE 1438.83 8
1745.76 FLYMRGDQMPTEEE 1745.75 27
1967.01 LQKLRDADTVTVDGVHAE 1967.01 4
2001.09 AMGGKRVVVRTLDIGGDKE 2001.69 1
2100.09 SVVIVGNDLTPSDTAQLNKE 2100.08 24
2149.96 FLYMRGDQMPTEEEQFE 2149.92 219
2451.33 FSMSATSILKARRQINGLSKNE 2451.31 26
2566.31 FVQGFATNIGGRTSHSAIMSRSLE 2566.28 211
2606.23 VDFFSIGTNDLIQYTLAADRMSE 2606.24 5
2678.50 RVSYLYQPYNPSILRLVKQVIE 2678.50 1
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and Y[PO3] (216 u) could be detected, and the sequence
DRVY(PO3)IHPF could be identified.
Other types of post-translational modifications have
been studied in Duesseldorf. Experiments concerning
the locating of intrapeptidic disulfur bonds using
MALDI-PSD will be published soon [52].
Figure 8. MALDI-PSD time-of-flight mass spectra of positive ions from two peptides of mass (a)
1135.6 u and (b) 1438.8 u, from the digest mixture shown in Figure 7. Both spectra were acquired at
20 kV under delayed extraction conditions.
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Protein Identification
The identification of a protein by MALDI time-of-flight
mass spectrometry starts with an accurate mass deter-
mination. In certain cases, the knowledge of the exact
mass of a protein in comparison with its theoretical
mass (calculated from the sequence) is sufficient infor-
mation to confirm (or infirm) that the observed mole-
cule is the expected one. A second step will consist of
performing a specific proteolytic digestion of an iso-
lated protein (after gel electrophoresis [53], HPLC [54,
55], CE [56], or affinity chromatography [57–59]) to
generate a set of cleavage peptides, which can be mass
analyzed by MALDI-TOF without any further purifica-
tion. The peptide map of this digest is, in principle,
unique to a protein and can be used to search databases
[60–66]. The MALDI TOF spectrum of positive ions
displayed in Figure 7 was obtained after a specific
enzymatic digestion of a protein by the endoprotease
glu-c (V8 E). This sample was given for a contest for the
4th “Arbeitstagung Mikromethoden in der Proteinche-
mie” meeting (Martinsried, Max-Planck-Inst. fu¨r Bio-
chemie, Martinsried, June 23–26, 1997, R. Kellner, F.
Lottspeich, H. E. Meyer, Organizers). From this spec-
trum, 49 ion signals were listed and used to perform a
database search. Result number one from the database
search attributed 24 ion signals as being peptides from
the phosphoenolpyruvate phosphotransferase protein
of Staphylococcus Aureus (Swissprot P51183, MW
63,219.4 u) covering 50% of the 572 amino acids of the
sequence. These peptides are listed in Table 3.
We see, looking at Table 3, that the mass accuracies
between the observed ion signals and the proposed
peptide sequences are in very good agreement, ex-
pressed by a standard deviation of the observed masses
of less than 15 ppm.
Because 25 ion signals out of 49 have not be identi-
fied, some having strong ion signal intensities (possibly
peptides either from autodigestion of the cleavage en-
zyme or from the studied protein but unidentified
because of post-translational modifications), one may
still have doubts with respect to the protein attribution.
To confirm this protein identification post-source decay
analyses have been performed on two of the peptides of
the digest at mass 1135.6 and 1438.8 u, respectively. The
PSD ion spectra of both peptides are presented in
Figure 8a, b. On each spectrum the fragmentation
scheme of the peptidic sequence predicted by the spe-
cific proteolysis of the phosphotransferase protein is
superimposed. In both cases, the good match between
the spectrum and the proposed amino acid sequence
clearly indicates that the correct protein has been iden-
tified.
The above protein identification protocol can be
easily performed when having isolated a single protein,
but it can also be employed when looking at a mixture
of up to three proteins [67]. This can, for example, be the
case when proteins within the same mass range are not
separated completely by gel electrophoresis. In the
same way as for a single isolated protein, the protein
mixture is submitted to a specific proteolytic agent to
form a set of peptides that can then be mass analyzed.
The first database search will usually propose as the
number one result one of the proteins of the mixture. A
second search can then be performed after subtraction
of all identified ion signals (peptides) from the mass list.
The number one result from this second search will
normally identify a second protein from the mixture.
These database search operations can be performed
until all of the components of the protein mixture have
been identified. At this stage it is, however, necessary to
control systematically the correctness of each protein
identification by post-source decay measurements of
one or two cleavage peptides.
Conclusion
Modern MALDI post-source decay time-of-flight mass
spectrometry has strong potential in decoding peptide
sequences either in combination with database search-
ing on the basis of partial sequence information or in
association with fast and easy to perform on-target
derivatization methods. The development of new frag-
ment ion spectrum interpretation software allows one,
in combination with database searching, to identify
rapidly peptide sequences. MALDI-PSD can also be of
major help in confirming protein identification by ob-
taining partial or complete sequence information of
cleavage peptides issued from specific enzymatic diges-
tions.
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